Nu-Med Plus (NUMD) Interest Coverage Ratio (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.87% |
| Sep 30, 2025 | 36.28% |
| Jun 30, 2025 | 44.86% |
| Mar 31, 2025 | -105.77% |
| Dec 31, 2024 | 46.68% |
| Sep 30, 2024 | -7.46% |
| Jun 30, 2024 | 22.06% |
| Mar 31, 2024 | 62.42% |
| Dec 31, 2023 | -265.35% |
| Sep 30, 2023 | 35.03% |
| Jun 30, 2023 | 15.41% |
| Dec 31, 2020 | -106.40% |
| Sep 30, 2020 | 51.04% |
| Jun 30, 2020 | -508.43% |
| Mar 31, 2020 | 24.60% |
| Dec 31, 2019 | -46.95% |
| Sep 30, 2019 | -160.47% |
| Jun 30, 2019 | -41.45% |
| Mar 31, 2019 | 32.94% |
| Dec 31, 2018 | -34.83% |
| Sep 30, 2018 | 213.52% |
| Jun 30, 2018 | 21.18% |
| Mar 31, 2018 | 103.69% |
| Dec 31, 2017 | -3,057.14% |
| Sep 30, 2017 | 12.44% |
| Jun 30, 2017 | 31.16% |
| Mar 31, 2017 | -98.70% |
| Dec 31, 2016 | 1,000.51% |
| Sep 30, 2016 | 287.75% |
| Jun 30, 2016 | 171.28% |
| Mar 31, 2016 | 105.88% |
| Dec 31, 2015 | -367.38% |
| Sep 30, 2015 | -22.93% |
| Jun 30, 2015 | 224.48% |
| Mar 31, 2015 | -77.11% |
| Dec 31, 2014 | 121.83% |
| Sep 30, 2014 | 19.17% |
| Jun 30, 2014 | 867.64% |
| Sep 30, 2013 | -86.82% |
| Jun 30, 2013 | -67.41% |
| Mar 31, 2013 | 165.10% |